INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
55 hedge funds and large institutions have $68.9M invested in Infinity Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Holders
55
Holding in Top 10
–
Calls
$275K
Puts
$282K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$946K | |
| 3 | +$910K | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$893K |
| 5 |
Two Sigma Advisers
New York
|
+$469K |
Top Sellers
| 1 | -$349K | |
| 2 | -$346K | |
| 3 | -$287K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$196K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$123K |